IBRX Latest Press Releases

-- November 4, 2026 --

ImmunityBio Announces First Patients in Europe Treated with ANKTIVA Plus BCG for BCG-unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ Business Wire 8:00 AM

-- October 21, 2026 --

ImmunityBio Announces Database Lock for Registrational Trial of Locally Delivered, Chemotherapy-Free ANKTIVA Plus BCG in BCG-Nave Non-Muscle Invasive Bladder Cancer Business Wire 7:30 AM

-- October 16, 2026 --

ImmunityBio Reports Phase 3 Data Showing 84% Cystectomy Avoidance at Three Years and Complete Responses Beyond 53 Months with ANKTIVA Plus BCG in BCG-Unresponsive NMIBC With CIS, With or Without Papillary Tumors Business Wire 11:49 AM

-- October 14, 2026 --

FDA Expands ANKTIVA Approval for BCG-Unresponsive Non-Muscle-Invasive Bladder Cancer to Cover Both Papillary and CIS Disease Business Wire 4:18 PM

-- October 8, 2026 --

ImmunityBio to Participate in the Piper Sandler Virtual Oncology Symposium Business Wire 8:30 AM

-- October 2, 2026 --

These High-Voltage Stocks Are Suddenly Impossible to Ignore Globe Newswire 11:44 AM

-- October 1, 2026 --

HLS Therapeutics Announces Board of Directors Changes PRNewswire 7:00 AM

-- September 14, 2026 --

PDS Biotech Announces Initial Closing of up to $22.3 Million PIPE Financing and the Appointment of Dr. Patrick Soon-Shiong to Its Board of Directors Globe Newswire 10:30 AM

-- August 10, 2026 --

ImmunityBio Appoints Dr. Jim Yong Kim, Former World Bank President and Global Health Leader, as Vice Chairman Business Wire 9:00 AM

-- August 4, 2026 --

ImmunityBio Reports Record Q2 2026 Net Product Revenue of $50.7 Million, Up 92% Year-Over-Year; First-Half Revenue Up 121% to $94.8 Million Business Wire 7:30 AM

-- July 29, 2026 --

ImmunityBio Receives United Arab Emirates (UAE) Marketing Authorization for ANKTIVA Across BCG-Unresponsive Non-Muscle Invasive Bladder Cancer for CIS and Papillary Disease and Metastatic Non-Small Cell Lung Cancer Business Wire 6:45 PM

-- June 8, 2026 --

Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet Globe Newswire 9:01 AM

Market Data Delayed 15 Minutes